Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib

John Nemunaitis, Sebastian Bauer, Jean Yves Blay, Khalil Choucair, Hans Gelderblom, Suzanne George, Patrick Schöffski, Margaret Von Mehren, John Zalcberg, Haroun Achour, Rodrigo Ruiz-Soto, Michael C. Heinrich

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences